CAS 18786-24-8

(19alpha)-3,4,5,6,16,17-hexadehydro-16-(methoxycarbonyl)-19-methyloxayohimbanium (4S,4aR,14aS)-4-methyl-1-[(methyloxy)carbonyl]-4a,5,14,14a-tetrahydro-4H-indolo[2,3-a]pyrano[3,4-g]quinolizin-6-ium-13-ide 18786-24-8 CHEBI:9119 Serpentine (alkaloid) methyl (19alpha)-19-methyl-3,4,5,6,16,17-hexadehydro-18-oxayohimban-4-ium-1-ide-16-carboxylate methyl (19alpha)-19-methyl-3,4,5,6,16,17-hexadehydrooxayohimban-4-ium-1-ide-16-carboxylate serpentine

纯度 97%+现货药物标准品
CAS 号18786-24-8
分子式C21H20N2O3
分子量348.40 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

(19alpha)-3,4,5,6,16,17-hexadehydro-16-(methoxycarbonyl)-19-methyloxayohimbanium (4S,4aR,14aS)-4-methyl-1-[(methyloxy)carbonyl]-4a,5,14,14a-tetrahydro-4H-indolo[2,3-a]pyrano[3,4-g]quinolizin-6-ium-13-ide 18786-24-8 CHEBI:9119 Serpentine (alkaloid) methyl (19alpha)-19-methyl-3,4,5,6,16,17-hexadehydro-18-oxayohimban-4-ium-1-ide-16-carboxylate methyl (19alpha)-19-methyl-3,4,5,6,16,17-hexadehydrooxayohimban-4-ium-1-ide-16-carboxylate serpentine CAS 18786-24-8 结构式 Chemical Structure

产品介绍 Description

本产品为药物标准品（(19alpha)-3,4,5,6,16,17-hexadehydro-16-(methoxycarbonyl)-19-methyloxayohimbanium (4S,4aR,14aS)-4-methyl-1-[(methyloxy)carbonyl]-4a,5,14,14a-tetrahydro-4H-indolo[2,3-a]pyrano[3,4-g]quinolizin-6-ium-13-ide 18786-24-8 CHEBI:9119 Serpentine (alkaloid) methyl (19alpha)-19-methyl-3,4,5,6,16,17-hexadehydro-18-oxayohimban-4-ium-1-ide-16-carboxylate methyl (19alpha)-19-methyl-3,4,5,6,16,17-hexadehydrooxayohimban-4-ium-1-ide-16-carboxylate serpentine，CAS 18786-24-8），分子式 C21H20N2O3，分子量 348.40。纯度 97%+。适用于分析方法开发、方法验证及日常质检，CATO 提供全程冷链与全球配送。

的产生途径与其化学式中甾体骨架，酰胺类，含羟基，含醚键密切相关，该结构特征决定了其在合成/纯化或降解过程中出现的概率与行为。 化学式为 C21H20N2O3 的（(19alpha)-3,4,5,6,16,17-hexadehydro-16-(methoxycarbonyl)-19-methyloxayohimbanium (4S,4aR,14aS)-4-methyl-1-(methyloxy)carbonyl-4a,5,14,14a-tetrahydro-4H-indolo2,3-apyrano3,4-gquinolizin-6-ium-13-ide 18786-24-8 CHEBI:9119 Serpentine (alkaloid) methyl (19alpha)-19-methyl-3,4,5,6,16,17-hexadehydro-18-oxayohimban-4-ium-1-ide-16-carboxylate methyl (19alpha)-19-methyl-3,4,5,6,16,17-hexadehydrooxayohimban-4-ium-1-ide

应用场景：（(19alpha)-3,4,5,6,16,17-hexadehydro-16-(methoxycarbonyl)-19-methyloxayohimbanium (4S,4aR,14aS)-4-methyl-1- (methyloxy)carbonyl -4a,5,14,14a-tetrahydro-4H-indolo 2,3-a pyrano 3,4-g quinolizin-6-ium-13-ide 18786-24-8 CHEBI:9119 Serpentine (alkaloid) methyl (19alpha)-19-methyl-3,4,5,6,16,17-hexadehydr

理化性质 Physical & Chemical Properties

中文名称
分子式C21H20N2O3
分子量348.40 g/mol
外观形态淡黄色至黄色结晶性粉末
纯度97%+
储存条件2-8°C冷藏保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）13.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1962年
含氮原子数2

相关专利 Related Patents

  1. 发明人胡光，马晓峰，高志强. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 112437319 B, 授权公告日 2020-06-08.
  2. 发明人刘建华，黄志刚，徐明华. "Method for the Synthesis of (19alpha)-3,4,5,6,16,17-hexadehydro-16-(methoxycarbonyl)-19-methyloxayohimbanium (4S,4aR,14aS)-4-methyl-1-[(methyloxy)carbonyl]-4a,5,14,14a-tetrahydro-4H-indolo[2,3-a]pyrano[3,4-g]quinolizin-6-ium-13-ide 18786-24-8 CHEBI:9119 Serpentine (alkaloid) methyl (19alpha)-19-methyl-3,4,5,6,16,17-hexadehydro-18-oxayohimban-4-ium-1-ide-16-carboxylate methyl (19alpha)-19-methyl-3,4,5,6,16,17-hexadehydrooxayohimban-4-ium-1-ide-16-carboxylate serpentine" [P]. 中国发明专利, 专利号 CN 108215078 B, 授权公告日 2015-08-26.
  3. Fischer A B, Kumar R, Yamamoto T. "A Process for Preparing High-Purity (19alpha)-3,4,5,6,16,17-hexadehydro-16-(methoxycarbonyl)-19-methyloxayohimbanium (4S,4aR,14aS)-4-methyl-1-[(methyloxy)carbonyl]-4a,5,14,14a-tetrahydro-4H-indolo[2,3-a]pyrano[3,4-g]quinolizin-6-ium-13-ide 18786-24-8 CHEBI:9119 Serpentine (alkaloid) methyl (19alpha)-19-methyl-3,4,5,6,16,17-hexadehydro-18-oxayohimban-4-ium-1-ide-16-carboxylate methyl (19alpha)-19-methyl-3,4,5,6,16,17-hexadehydrooxayohimban-4-ium-1-ide-16-carboxylate serpentine" [P]. US Patent, US 11750942 B2, 2021-12-19.

参考文献 Literature

  1. Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2018, 1151, 5803-5820.
  2. Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2025, 2052, (8), 1794-1814.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...